Market Cap 1.10B
Revenue (ttm) 300,000.00
Net Income (ttm) -269.95M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -89,983.33%
Debt to Equity Ratio 0.03
Volume 1,028,300
Avg Vol 890,382
Day's Range N/A - N/A
Shares Out 81.49M
Stochastic %K 1%
Beta 1.05
Analysts Strong Sell
Price Target $39.27

Latest News on VRDN

Viridian Therapeutics: A Clearer Picture Emerges (Rating Upgrade)

Dec 17, 2024, 12:41 PM EST - 3 months ago

Viridian Therapeutics: A Clearer Picture Emerges (Rating Upgrade)


Viridian Therapeutics' Superior Prospects Make It A Buy

Oct 23, 2024, 4:02 PM EDT - 5 months ago

Viridian Therapeutics' Superior Prospects Make It A Buy


3 Small Biotech Stocks With The 'Big Mo' Right Now

Sep 19, 2024, 12:54 PM EDT - 6 months ago

3 Small Biotech Stocks With The 'Big Mo' Right Now

AUPH CORT


Top 3 Health Care Stocks You May Want To Dump This Quarter

Jul 30, 2024, 10:13 AM EDT - 8 months ago

Top 3 Health Care Stocks You May Want To Dump This Quarter

CPRX VRNA


3 Biotech Names With Potential Catalysts By Year End

Jul 29, 2024, 3:32 PM EDT - 8 months ago

3 Biotech Names With Potential Catalysts By Year End

CADL RCKT


Wedbush's Laura Chico talks biotech investing in 2024

Dec 26, 2023, 5:21 PM EST - 1 year ago

Wedbush's Laura Chico talks biotech investing in 2024

EWTX IBB NBIX XBI


Viridian: Market May Be Wrong In Its Disapproval

Dec 12, 2023, 8:00 AM EST - 1 year ago

Viridian: Market May Be Wrong In Its Disapproval